NDA[removed]S-023 NDA[removed]S-044 NDA[removed]S-003 Page[removed]

First Page		Document Content
Date: 2005-02-11 16:13:41 Pfizer Organofluorides Phenols Benzamides Nelfinavir Efavirenz Lamivudine Simvastatin Azithromycin Chemistry Organic chemistry Protease inhibitors		NDA[removed]S-023 NDA[removed]S-044 NDA[removed]S-003 Page[removed] Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 386,34 KB Share Document on Facebook

	Therapeutic Drug Monitoring Immunoassay for Efavirenz Kenneth C. Kasper1, Joanne Valencia1, Ki Chung1, Byung Sook Moon1, Johnny Valdez1, Anura Jayewardene2, Patricia Lizak2, and Francesca T. Aweeka2 ARK Diagnostics, Inc. DocID: 1uWz5 - View Document
	The ARK EFV-TestTM: A Rapid, Automated Immunoassay for Therapeutic Drug Monitoring of Efavirenz Michael K. Helms1, Diane T. Holland2, Rowena J. Espina-Quinto2, Ellen K. Stefanski2, Byung S. Moon1, Johnny J. Valdez1, and DocID: 1u0vo - View Document
	BMS_Gilead_Logo_FINAL.eps DocID: 1m38a - View Document
	Patient Information ATRIPLA® (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section "MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA." Generic name: efaviren DocID: 1lg5I - View Document
	SUPPLEMENT ARTICLE Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs Stefan Mauss1 and Hartwig Klinker2 1 DocID: 1giaR - View Document